文献速递重症综合管理与镇静镇痛儿科与产科急症

儿童重症监护室推迟一周肠外营养对2年发育结局的影响:PEPaNIC国际随机对照试验的2年随访

Long-term developmental effects of withholding parenteral nutrition for 1 week in the paediatric intensive care unit: a 2-year follow-up of the PEPaNIC international, randomised, controlled trial.
PubMed 文献 · Lancet Respir Med · 2018-09-14
一句话结论PICU推迟补充肠外营养1周不增加2年死亡率、不损害体格与神经认知发育,并改善抑制控制等执行功能。

PEPaNIC多中心随机对照试验此前显示,与早期肠外营养相比,在PICU推迟补充肠外营养1周(晚期肠外营养)减少感染并加速危重症儿童康复。本预设2年随访研究纳入原试验患者,与年龄性别匹配、从未入住新生儿ICU或PICU的健康儿童比较,评估体格与神经认知发育。2年随访时晚期组60/717例(8%)与早期组63/723例(9%)死亡(p=0.81),晚期组68/717例(9%)与早期组91/723例(13%)因残疾过重无法完成神经认知评估(p=0.059),786例患者(晚期395例、早期391例)同意测试,最终786例患者与405名健康对照儿童在2014年8月4日至2018年1月19日间完成长期结局测试并纳入插补模型。晚期肠外营养未对体格数据、健康状态或神经功能产生不良影响,并改善家长或照护者报告的执行功能(晚期 vs 早期β估计-2.258,95%CI -4.012至-0.504;p=0.011),具体为抑制(-3.422,-5.171至-1.673;p=0.0001)、工作记忆(-2.016,-3.761至-0.270;p=0.023)与元认知(-1.957,-3.694至-0.220;p=0.027),外化行为问题(β估计-1.715,95%CI -3.325至-0.106;p=0.036)与视觉-运动整合(0.468,0.087至0.850;p=0.016)亦改善;Bonfe

要点

  • 2年随访:晚期肠外营养组60/717例(8%)死亡 vs 早期组63/723例(9%),p=0.81,推迟1周未增加死亡。
  • 晚期组68/717例(9%)vs 早期组91/723例(13%)因残疾过重无法完成神经认知评估,p=0.059,未达统计学显著。
  • 晚期 vs 早期肠外营养改善家长或照护者报告的执行功能(β估计-2.258,95%CI -4.012至-0.504;p=0.011)。
  • 抑制控制(β估计-3.422,95%CI -5.171至-1.673;p=0.0001)在Bonferroni校正后仍显著。
  • 晚期肠外营养未对体格数据、健康状态或神经功能产生不良影响。

适用人群与场景

  • PEPaNIC试验纳入的PICU患儿,来自比利时鲁汶大学医院、荷兰鹿特丹伊拉斯姆斯医学中心-索菲亚儿童医院、加拿大埃德蒙顿斯托勒里儿童医院。
  • 对照为按年龄和性别匹配、从未入住新生儿ICU或PICU的健康儿童405名。
  • 786例患者(晚期肠外营养组395例、早期肠外营养组391例)同意并完成长期结局测试,纳入插补模型后的多变量分析。

处置流程与药物剂量

  • 干预为在PICU推迟补充肠外营养1周(晚期肠外营养),对照为早期肠外营养;原文未给出具体剂量方案。

研究设计与关键结果

  • 预设2年随访研究:PEPaNIC多中心随机对照试验的随访,786例患者与405名健康对照儿童在2014年8月4日至2018年1月19日间完成长期结局测试。
  • 2年随访死亡:晚期肠外营养组60/717例(8%) vs 早期肠外营养组63/723例(9%),p=0.81。
  • 因残疾过重无法完成神经认知评估:晚期组68/717例(9%) vs 早期组91/723例(13%),p=0.059。
  • 执行功能(家长或照护者报告):晚期 vs 早期肠外营养β估计-2.258(95%CI -4.012至-0.504;p=0.011)。
  • 抑制:β估计-3.422(95%CI -5.171至-1.673;p=0.0001);工作记忆:-2.016(-3.761至-0.270;p=0.023);元认知:-1.957(-3.694至-0.220;p=0.027)。
  • 外化行为问题:β估计-1.715(95%CI -3.325至-0.106;p=0.036);视觉-运动整合:0.468(95%CI 0.087至0.850;p=0.016)。
  • Bonferroni校正后抑制控制效应仍显著(p=0.0001)。
  • 晚期肠外营养未对体格数据、健康状态或神经功能产生不良影响。

证据类型、等级与局限

  • 证据类型:国际多中心随机对照试验(PEPaNIC)的预设2年随访研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,在PICU推迟早期肠外营养1周未对生存、体格数据、健康状态与神经认知发育产生负面影响,并在PICU入住2年后改善抑制控制。
  • 该随访结果支持PEPaNIC原试验中推迟补充肠外营养1周的做法在2年发育结局上未显示危害。

指南或共识出处

  • PEPaNIC国际随机对照试验(ClinicalTrials.gov注册号NCT01536275)的2年随访研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The paediatric early versus late parenteral nutrition in critical illness (PEPaNIC) multicentre, randomised, controlled trial showed that, compared with early parenteral nutrition, withholding supplemental parenteral nutrition for 1 week in the paediatric intensive care unit (PICU; late parenteral nutrition) reduced infections and accelerated recovery from critical illness in children. We aimed to investigate the long-term impact on physical and neurocognitive development of early versus late parenteral nutrition.

METHODS: In this preplanned 2-year follow-up study, all patients included in the PEPaNIC trial (which was done in University Hospitals Leuven, Belgium; Erasmus Medical Centre-Sophia Children's Hospital, Rotterdam, Netherlands; and Stollery Children's Hospital, Edmonton, AB, Canada) were approached for possible assessment of physical and neurocognitive development compared with healthy children who were matched for age and sex, and who had never been admitted to a neonatal ICU or a PICU. Assessed outcomes comprised anthropometric data; health status; parent-reported or caregiver-reported executive functions and emotional and behavioural problems; and tests for intelligence, visual-motor integration, alertness, motor coordination, inhibitory control, cognitive flexibility, and memory. To address partial responses among the children tested, we did multiple data imputation by chained equations before univariable and multivariable linear and logistic regression analyses adjusted for risk factors. This trial is registered with ClinicalTrials.gov, number NCT01536275.

FINDINGS: At the 2-year follow-up, 60 (8%) of 717 children who received late parenteral nutrition and 63 (9%) of 723 children who received early parenteral nutrition had died (p=0·81). 68 (9%) of 717 children who received late and 91 (13%) of 723 children who received early parenteral nutrition were too disabled for neurocognitive assessment (p=0·059), and 786 patients (395 assigned to late and 391 assigned to early parenteral nutrition) consented for testing. 786 patients and 405 healthy control children underwent long-term outcome testing between Aug 4, 2014, and Jan 19, 2018, and were included in the imputation model for subsequent multivariable analyses. Late parenteral nutrition did not adversely affect anthropometric data, health status, or neurological functioning, and improved parent-reported or caregiver-reported executive functioning (late vs early parenteral nutrition β estimate -2·258, 95% CI -4·012 to -0·504; p=0·011), more specifically inhibition (-3·422, -5·171 to -1·673; p=0·0001), working memory (-2·016, -3·761 to -0·270; p=0·023), and meta-cognition (-1·957, -3·694 to -0·220; p=0·027). Externalising behavioural problems (β estimate -1·715, 95% CI -3·325 to -0·106; p=0·036) and visual-motor integration (0·468, 0·087 to 0·850; p=0·016) were also improved in the late parenteral nutrition group compared with the early parenteral nutrition group. After Bonferroni correction for multiple comparisons, the effect on inhibitory control remained significant (p=0·0001).

INTERPRETATION: Withholding early parenteral nutrition for 1 week in the PICU did not negatively affect survival, anthropometrics, health status, and neurocognitive development, and improved inhibitory control 2 years after PICU admission.

FUNDING: European Research Council Advanced Grant, Methusalem programme provided by the Flemish Government, Flemish Agency for Innovation by Science and Technology (IWT), Research Foundation Flanders (FWO), Sophia Children's Hospital Foundation (SSWO), Stichting Agis Zorginnovatie, Erasmus Trustfonds, and European Society for Parenteral and Enteral Nutrition (ESPEN) research grant.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Verstraete S, Verbruggen SC, Hordijk JA, et al. Long-term developmental effects of withholding parenteral nutrition for 1 week in the paediatric intensive care unit: a 2-year follow-up of the PEPaNIC international, randomised, controlled trial. Lancet Respir Med. 2018. PMID: 30224325. doi:10.1016/S2213-2600(18)30334-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。